Assay ID | Title | Year | Journal | Article |
AID69537 | Relative binding affinity for estrogen receptor using a tritium labeled estrogen as the tracer and immature rat uterine cytosol | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID80541 | Cytotoxicity against colon HCT116 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID200462 | In vitro cytotoxicity value corresponding to 50% growth inhibition against SN12C (renal) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID57875 | Cytotoxicity against prostate DU-145 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID57874 | The In vitro cytotoxicity value corresponding to 50% growth inhibition against DU-145 (prostate) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID214753 | In vitro cytotoxicity value corresponding to 50% growth inhibition against UACC-62(melanoma) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID69678 | Relative binding affinity (RBA) for estrogen receptor at 25 degree C | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID81508 | In vitro cytotoxicity value corresponding to 50% growth inhibition against HOP-62(non small cell lung) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID214754 | Cytotoxicity against melanoma UACC-62 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID145429 | In vitro cytotoxicity value corresponding to 50% growth inhibition against OVCAR-3 (ovarian) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID145430 | Cytotoxicity against ovarian OVCAR-3 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID214035 | Evaluated for inhibition of tubulin polymerization. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID90282 | Mean graph midpoint for all human cancer cell line cytotoxicity. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID81509 | Cytotoxicity against lung HOP-62 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID214164 | Compound was evaluated for inhibition of colchicine binding to tubulin in experiment I. | 2000 | Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
| Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability. |
AID214165 | Compound was evaluated for inhibition of colchicine binding to tubulin in experiment II. | 2000 | Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
| Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability. |
AID200441 | Cytotoxicity against renal SN12C cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID69681 | Relative binding affinity (RBA) for estrogen receptor at 0C | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID213998 | Inhibition of polymerization of purified bovine tubulin | 2000 | Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
| Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability. |
AID102159 | In vitro cytotoxicity value corresponding to 50% growth inhibition against MDA-MB-435 (breast) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID201282 | Cytotoxicity against CNS SF-539 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID90281 | Mean graph midpoint for growth inhibition of all human cancer cell lines | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID214038 | In vitro inhibition of tubulin polymerization. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID214193 | Percentage inhibition of colchicine binding to tubulin. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID90302 | Tested for cytotoxicities and mean graph midpoint (MGM) for growth inhibition of all 55 human cell lines | 2000 | Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
| Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability. |
AID214191 | Evaluated for % inhibition of colchicine binding to tubulin. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID247705 | Inhibitory concentration required against growth of HUVEC cancer cell line | 2004 | Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
| Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization. |
AID201311 | The In vitro cytotoxicity corresponding to 50% growth inhibition against SF-59 (central nervous system) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID80539 | In vitro cytotoxicity value corresponding to 50% growth inhibition against HCT116 (colon) cell line. | 1997 | Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
| Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth. |
AID102160 | Cytotoxicity against breast MDA-MB-435 cancer cell lines. | 1995 | Journal of medicinal chemistry, Jun-09, Volume: 38, Issue:12
| Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. |
AID247636 | Inhibitory concentration against growth of MDA-MB-231 cancer cell line | 2004 | Journal of medicinal chemistry, Oct-07, Volume: 47, Issue:21
| Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |